Related Experiment Video
Updated: Aug 3, 2026
04:09
Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
Published on: September 20, 2024
Interventions in heart and thyroid surgery: can they be safely combined?
Bassam Abboud1, Ghassan Sleilaty, Bechara Asmar
1Department of General and Endocrine Surgery, Hotel Dieu deFrance Hospital, Faculty of Medicine, Saint-Joseph University, Alfred Naccache Street, Beirut, Lebanon. dbabboud@yahoo.fr
Summary
Combined heart and thyroid surgery is feasible for patients with cardiac disease and thyroid issues. This approach poses minimal risk, demonstrating a safe option for managing concurrent conditions.
Area of Science:
- Cardiothoracic Surgery
- Endocrine Surgery
Background:
- Thyroid diseases frequently coexist with cardiac conditions.
- Managing both requires careful consideration of surgical timing and patient safety.
Purpose of the Study:
- To assess the feasibility and safety of combined cardiac and thyroid surgical interventions.
- To evaluate outcomes in patients undergoing simultaneous or staged procedures.
Main Methods:
- Retrospective analysis of 2530 cardiac surgeries.
- Identified six patients who underwent combined cardiac and thyroid surgery between 1996 and 2003.
- Reviewed patient demographics, cardiac conditions, thyroid pathologies, and perioperative management.
Main Results:
- Six patients (4 male, 2 female) had combined procedures for coronary artery disease, valvular disease, or both, along with thyroid pathologies.
- All patients received perioperative and postoperative anticoagulation with intravenous heparin.
- No instances of cervical bleeding or hemodynamic/cardiovascular compromise were observed.
Conclusions:
- Combined staged thyroid and cardiac surgery is a feasible approach.
- This combined surgical strategy presents a low risk profile for patients with concurrent cardiac and thyroid diseases.
Related Concept Videos
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
01:28Imaging Studies for Cardiovascular System V: CT
Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
01:26Cardiac Catheterization IV: Nursing Management
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...